Abiopharma

News list

Director Deadman Davis R 🟢 acquired 1.3K shares of Triumph Financial, Inc. (TFIN) Transaction Date: May 01, 2026 | Filing ID: 030635

Full text

News bot May 5, 2026, 8:32 p.m.
🔍 Deadman Davis R (Director)

Company: Triumph Financial, Inc. (TFIN)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 1,258
- Total shares held: 26,500
Detailed Transactions and Holdings:
- Acquired 1,258 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,434.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Depository Shares (Direct)
  Date: 2026-05-01 | Code: H | shares_owned_after: 26,500.00 | Footnotes: F3
Footnotes:
- F1: Shares represented by time-vested restricted stock units that vest one year from date of award.
- F2: Consists of (i) 9,176 shares beneficially owned by reporting person, and (ii) 1,258 shares of restricted stock or restricted stock units of the reporting person subject to future vesting requirements.
- F3: Each Depository Shares represents a 1/40th interest in a share of the Issuer's 7.125% Series C Fixed Rate Non-Cumulative Perpetual Preferred Stock, par value $0.01 per share.